David Daniel Schwartz, PhD
Dr. Schwartz's main clinical and training interests are: neuropsychological assessment of children with chronic illness (e.g., type 1 diabetes, congenital heart conditions), and cognitive and psychosocial risk screening (including use of predictive analytics) to identify patients at risk for problematic medical adherence and deleterious health outcomes. His research is closely tied to his clinical work and is focused on 1) the relationship between neurocognitive and executive functioning and medical adherence (including illness-related risk-taking), 2) prediction of risk for complications of chronic illness (e.g., diabetic ketoacidosis), and 3) neurocognitive outcomes of chronic illness (e.g., chronic kidney disease, urea cycle disorders, and different rare genetic syndromes).
Schwartz DD, Axelrad MA. Healthcare partnerships for promoting pediatric adherence: promoting collaborative management for pediatric chronic illness care. SpringerBriefs in Child Health. Houston, Texas: Springer (In press).
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.